Home › Funds › EARNEST PARTNERS LLC › QGEN
EARNEST PARTNERS LLC position in QGEN
QIAGEN NV · Health Care
EARNEST PARTNERS LLC reported holding 4,652,297 shares of QGEN (QIAGEN NV) in its Q3 2026 13F filing — a position valued at US$203.6M, representing 0.80% of its reported portfolio and ranking #36 among its reported holdings. EARNEST PARTNERS LLC has disclosed QGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How EARNEST PARTNERS LLC's QGEN position evolved
EARNEST PARTNERS LLC first disclosed a stake in QGEN in Q3 2023 at 1,511,503 shares (US$61.2M). The position peaked in Q3 2026 at 4,652,297 shares, worth US$203.6M. Across 13 filings, EARNEST PARTNERS LLC increased the stake 8 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 4,652,297 shares valued at US$203.6M — an increase of 78,842 shares quarter over quarter.. Notable position changes include a 85% increase in Q1 2024 (shares fell 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.51M | $61.22M | New |
| Q4 2023 | 1.85M | $82.89M | Add |
| Q1 2024 | 3.43M | $147.35M | Add |
| Q2 2024 | 3.81M | $156.44M | Add |
| Q3 2024 | 3.94M | $179.45M | Add |
| Q4 2024 | 4.00M | $178.23M | Add |
| Q1 2025 | 3.81M | $152.84M | Reduce |
| Q2 2025 | 4.20M | $201.96M | Add |
| Q3 2025 | 4.21M | $188.03M | Hold |
| Q4 2025 | 4.19M | $188.33M | Hold |
| Q1 2026 | 3.87M | $154.89M | Reduce |
| Q2 2026 | 4.57M | $178.82M | Add |
| Q3 2026 | 4.65M | $203.58M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About QGEN and 13F data
QGEN (QIAGEN NV) is a Health Care company. 27 other funds we track also report a position in QGEN — the largest reported positions include Fivespan Partners, LP (US$237.6M), Helikon Investments Ltd (US$100.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding QGEN
- Fivespan Partners, LP 5.43M sh · $237.58M · Q3 2026
- Helikon Investments Ltd 2.29M sh · $100.28M · Q3 2026
More on EARNEST PARTNERS LLC
FAQ
How long has EARNEST PARTNERS LLC held QGEN?
EARNEST PARTNERS LLC has disclosed QGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is EARNEST PARTNERS LLC's current position in QGEN?
As of Q3 2026, EARNEST PARTNERS LLC holds 4.65M shares of QGEN (QIAGEN NV), valued at $203.58M, representing 0.80% of its reported portfolio and ranking #36.
Has EARNEST PARTNERS LLC been buying or selling QGEN?
In the latest 13F filing (Q3 2026), EARNEST PARTNERS LLC increased its position in QGEN. The position peaked in Q3 2026 at 4.65M shares.
Which other funds hold QGEN?
Other major institutional holders of QGEN include Fivespan Partners, LP, Helikon Investments Ltd, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.